Drugs / Taribavirin
Taribavirin
also known as
Viramidine · Taribavirin hcl · TARIBAVIRIN HYDROCHLORIDE · Taribavirina · Taribavirine · TBV
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00446134 | Mar 2007 → Apr 2008 | chronic hepatitis C virus infection | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00305383 | Nov 2005 → May 2007 | chronic hepatitis C virus infection | Bausch Health Americas, Inc. | Terminated | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00093093 | Jun 2004 → May 2006 | chronic hepatitis C virus infection | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00230958 | Dec 2003 → Jan 2006 | chronic hepatitis C virus infection | Bausch Health Americas, Inc. | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Taribavirin | “Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)” NCT00446134 ↗ |
| Known as | Taribavirin hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111108 ↗ |
| Known as | TARIBAVIRIN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111108 ↗ |
| Known as | Taribavirina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111108 ↗ |
| Known as | Taribavirine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111108 ↗ |
| Known as | TBV | “The study aimed to determine if weight-based dosing of taribavirin (TBV), an oral prodrug of ribavirin (RBV), demonstrated efficacy comparable to RBV while maintaining its...” PMID 20721883 ↗ Oct 2010 |
| Known as | Viramidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00230958 ↗ |
| Modality | Small molecule | — CHEMBL2111108 ↗ |
| Route | Oral | “Oral taribavirin tablet 20 mg/kg/day (Actual doses were 20-24 mg/kg/day) BID” NCT00446134 ↗ |